Cardiovascular risk factors in primary hyperparathyroidism

Journal of Endocrinological Investigation

Volumn 32, Issue 4, 2009, Pages 317-321

  Luboshitzky, R ^a   Chertok Schaham, Y ^a   Lavi, I ^b   Ishay, A ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Hypercalcemia; Insulin resistance metabolic syndrome; Primary hyperparathyroidism

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; RISK FACTOR; TREATMENT INDICATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 70349484931     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345719     Document Type: Article

References (25)

1. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 2003, 27: 216-222 (Pubitemid 36926340)
2. Anderson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease- a review. Eur Heart J 2004, 25: 1776-1787 (Pubitemid 39330228)
3. Steffenelli T, Abela C, Frank H, et al. Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. J Clin Endocrinol Metab1997, 82: 106-112
4. Khaleeli AA, Johnson JN, Taylor WH. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes Metab Res Rev 2007, 3: 43-48
5. Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf) 1992, 37: 147-155
6. Langle F, Abeta C, Koller-Strametz J. Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J Surg 1994, 18: 619-624 (Pubitemid 24273866)
7. Lundgren E, Ljunghal S, Akerstrom G, Hetta J, Mallmin H, Rastad J. Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism. Surgery 1998, 124: 980-985
8. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117: 503-511
9. Blankenberg S, McQueen MJ, Smieja M. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation 2006, 114: 201-208 (Pubitemid 44297113)
10. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome, An American Heart Association/National Heart, Lung, and blood Institute Scientific Statement Executive Summary. Circulation 2005, 112: e285-e290.
11. Fernandez-real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003, 24: 278-301. (Pubitemid 36724371)
12. Yusuf S, Hawken S, Ounpuu S. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005, 366: 1640-1649 (Pubitemid 41552419)
13. st century. J Clin Endocrinol Metab 2002, 87: 5353-5361 (Pubitemid 36034328)
14. Wallace TM, Levy J.C, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004, 27: 1487-1495
15. Saleh FN, Schirmet H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003, 24: 2054-2060 (Pubitemid 37420453)
16. Smith JC, Page, MD, John R. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85: 3515-3519 (Pubitemid 30828544)
17. Fallo F, Camporese G, Capitelli E, Anderozzi M, Mantero F, Lumachi F. Ultrasound evaluation of carotid artery in primary hyperparathyroidism. J Clin Endocrinol Metab 2003, 88: 2096-2099 (Pubitemid 36549882)
18. Almqvist WG, Bondeson AG, Bondeson L, Nissborg A, Smedgard P, Svensson SE. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery 2002, 132: 1126-1132 (Pubitemid 36026965)
19. Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: A meta analysis. J Clin Endocrinol Metab 2005, 90: 1525-1530
20. Grey AB, Evans MC, Stapleton JP, Reid IR. Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Inter Med1994, 121: 745-749
21. Lakka HM, Laaksonen DE, Lakka TA. The metabolic syndrome and total and cardiovascular disease. JAMA 2002, 288: 2709-2716
22. Saely CH, Aczel S, Marte T, Langer P, Hoefle G, Drexel H. The metabolic syndrome. Insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients J Clin Endocrinol Metab 2005, 90: 5698-5703
23. Westerdahl J, Valdemarsson S, Lindblom P, Bergenfelz A. Urate and arteriosclerosis in primary hyperparathyroidism. Clin Endocrinol 2001, 54: 805-811
24. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-a are elevated in primary hyperparathyroidism and correlate with markers of bone resorption-A clinical research center study. J Clin Endocrinol Metab 1996, 81: 3450-3454 (Pubitemid 26339897)
25. Ogard GC, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 2005, 63: 493-498 (Pubitemid 41626742)